文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

Hippo信号通路对间充质干细胞修复急性呼吸窘迫综合征肺损伤的影响

[Effects of Hippo signaling pathway on lung injury repair by mesenchymal stem cells in acute respiratory distress syndrome].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2019-01-01
一句话结论小鼠ARDS模型中,低表达LATS2抑制Hippo通路可促进经气管移植的骨髓间充质干细胞在肺内滞留并分化为II型肺泡上皮细胞,减轻肺水肿、上皮通透性、炎症及纤维化。

该研究为小鼠实验,通过慢病毒载体构建低表达LATS2的小鼠骨髓间充质干细胞(mMSCs),将6-8周龄雄性C57BL/6小鼠随机分为四组(每组n=36),经气管注射2 g/L脂多糖50 μL复制ARDS模型,4小时后经气管移植5×10^4 mMSCs(空载体或shLATS2载体),对照组注射等量PBS。结果显示,与空载体组相比,shLATS2组第3天肺内荧光信号强度、GFP阳性细胞数及分化为II型肺泡上皮细胞比例均显著增高,且随时间下降;与ARDS组相比,两移植组第14天SPC和Occludin表达显著升高,第3天BALF中TP、ALB、IL-1β、IL-6显著降低、IL-10显著升高,shLATS2组上述指标均较空载体组进一步改善,肺湿重/体重比也显著低于ARDS组和空载体组。结论提示抑制Hippo通路可能促进mMSCs修复ARDS肺损伤,但证据限于动物实验。

要点

  • 小鼠ARDS模型中,经气管移植低表达LATS2的mMSCs较空载体mMSCs显著提高第3天肺内滞留(荧光强度0.039±0.005 vs. 0.017±0.002)和GFP阳性细胞数(29.65±6.98 vs. 17.50±4.58 cells/HP)。
  • shLATS2组mMSCs分化为II型肺泡上皮细胞比例显著高于空载体组[(64.12±15.29)% vs.(19.64±3.71)%]。
  • 与ARDS组相比,两移植组第14天SPC和Occludin表达显著升高、第3天BALF中TP、ALB、IL-1β、IL-6显著降低、IL-10显著升高,shLATS2组改善更明显。
  • shLATS2组肺湿重/体重比显著低于ARDS组和空载体组(9.85±1.51 vs. 16.78±1.92、14.88±1.74 mg/g)。
  • 上述结果均来自小鼠实验,不能直接转化为临床推荐。

适用人群与场景

  • 6-8周龄雄性C57BL/6小鼠,经气管注射2 g/L脂多糖50 μL复制ARDS模型。
  • 对照为经气管注射等量生理盐水的正常小鼠。

处置流程与药物剂量

  • 经气管注射2 g/L脂多糖50 μL复制小鼠ARDS模型。
  • 建模4小时后经气管移植5×10^4个mMSCs(空载体或shLATS2慢病毒载体转染),对照组建模后4小时经气管注射等量PBS。
  • 于建模后3、7、14天处死小鼠,取肺组织和支气管肺泡灌洗液检测。

研究设计与关键结果

  • 研究类型为小鼠实验,四组每组n=36:正常盐水对照组、ARDS组、MSC-shcontrol组、MSC-shLATS2组。
  • 第3天shLATS2组肺荧光信号强度显著高于空载体组(0.039±0.005 vs. 0.017±0.002,P<0.05),GFP阳性细胞数也显著增高(29.65±6.98 vs. 17.50±4.58 cells/HP,P<0.05),均随时间下降。
  • shLATS2组分化为II型肺泡上皮细胞比例显著高于空载体组[(64.12±15.29)% vs.(19.64±3.71)%,P<0.05]。
  • 与盐水对照组相比,ARDS组SPC和Occludin表达显著降低,肺湿重/体重比及BALF中TP、ALB、炎症因子显著升高,肺损伤评分和纤维化评分显著增高。
  • 与ARDS组相比,两移植组第14天SPC和Occludin表达显著升高(SPC/β-actin:0.51±0.12、0.68±0.10 vs. 0.27±0.08;Occludin/β-actin:0.49±0.19、0.79±0.11 vs. 0.25±0.08,均P<0.05),第3天BALF中TP、ALB、IL-1β、IL-6显著降低(TP:8.08±1.72、5.12±0.87 vs. 12.55±2.09 g/L;ALB:0.71±0.21、0.44±0.18 vs. 1.18±0.29 g/L;IL-1β:99.26±14.32、60.11±8.58 vs. 161.86±25.17 ng/L;
  • shLATS2组上述指标均较空载体组显著改善(均P<0.05),肺湿重/体重比显著低于ARDS组和空载体组(9.85±1.51 vs. 16.78±1.92、14.88±1.74 mg/g,均P<0.05)。

证据类型、等级与局限

  • 证据类型:小鼠实验(动物研究)。
  • 作者结论:抑制Hippo信号通路(低表达LATS2)可促进mMSCs在ARDS小鼠肺内滞留并分化为II型肺泡上皮细胞,改善肺水肿和肺泡上皮通透性,调节肺部炎症反应,减轻肺组织病理损伤和纤维化。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 该研究为小鼠实验,结果不能直接用于急诊或ICU临床决策。
  • 原文结论未据此给出临床推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To investigate the effects of Hippo signaling pathway on lung injury repair of mesenchymal stem cells (MSC) in acute respiratory distress syndrome (ARDS) and its mechanism.

METHODS: Mouse bone marrow-derived MSC (mMSCs) cell lines with low expression of large tumor suppressor 2 (LATS2) were constructed by lentiviral vector transfection. Male C57BL/6 mice aging 6-8 weeks old were divided into four groups according to random number table (n = 36). The ARDS animal model (ARDS group) was reproduced by intratracheally injection of 2 g/L lipopolysaccharide (LPS) 50 μL, the normal saline (NS) control group was injected with an equal volume of NS. After 4 hours of model reproduction, 5×104 mMSCs transfected with blank lentivirus vector (MSC-shcontrol group) or shLATS2 lentivirus vector (MSC-shLATS2 group) were transplanted intratracheally, while NS control group and ARDS group were injected with equal volume of phosphate buffered saline (PBS). Mice were sacrificed at 3, 7, and 14 days after modeling, and lung tissue and bronchoalveolar lavage fluid (BALF) were harvested. Near-infrared fluorescence imaging, immunofluorescence staining and Western Blot were used to track mMSCs in lung tissue. Retension and proportion of mMSC differentiation into type II alveolar epithelial cells (AEC II) were evaluated. Lung tissue wet weight/body weight ratio (LWW/BW) and total protein (TP) and albumin (ALB) in BALF were determined to reflect pulmonary edema. The expression of Occludin protein in lung epithelium was tested by Western Blot to reflect permeability of epithelium. The levels of interleukins (IL-1β, IL-6, IL-10) in BALF were assessed by enzyme-linked immunosorbent assay (ELISA) to reflect lung inflammation. Hematoxylin-eosin (HE) staining and modified Masson staining were carried out, and the scores were assessed to reflect lung injury and evaluate pulmonary fibrosis.

RESULTS: The signal intensity of isolated lung fluorescence images at 3 days in the MSC-shLATS2 group was significantly higher than that in the MSC-shcontrol group (fluorescence intensity: 0.039±0.005 vs. 0.017±0.002, P < 0.05), the number of green fluorescent protein (GFP)-positive cells in lung tissue was also significantly higher than that in the MSC-shcontrol group (cells/HP: 29.65±6.98 vs. 17.50±4.58, P < 0.05), but they all decreased with time; and the proportion of mMSCs differentiated into AEC II was significantly increased [(64.12±15.29)% vs. (19.64±3.71)%, P < 0.05]. Compared with the NS control group, the levels of surface active protein C (SPC) and Occludin protein in the ARDS group were significantly decreased, LWW/BW ratio and TP, ALB and inflammatory factors levels in BALF were significantly increased; extensive alveolar and interstitial edema, hemorrhage and diffuse inflammatory cell infiltration were found in lung tissue, and the lung injury score was significantly increased; collagen fibers were deposited in alveolar septum and alveolar cavity, and pulmonary fibrosis score was also increased significantly. Compared with the ARDS group, the expression levels of SPC and Occludin at 14 days in the MSC-shcontrol group and the MSC-shLATS2 group were significantly increased (SPC/β-actin: 0.51±0.12, 0.68±0.10 vs. 0.27±0.08, Occludin/β-actin: 0.49±0.19, 0.79±0.11 vs. 0.25±0.08, all P < 0.05), TP, ALB, IL-1β, IL-6 levels in BALF at 3 days were significantly decreased [TP (g/L): 8.08±1.72, 5.12±0.87 vs. 12.55±2.09; ALB (g/L): 0.71±0.21, 0.44±0.18 vs. 1.18±0.29, IL-1β (ng/L): 99.26±14.32, 60.11±8.58 vs. 161.86±25.17, IL-6 (ng/L): 145.54±13.29, 101.74±11.55 vs. 258.79±27.88, all P < 0.05], and IL-10 was significantly increased (ng/L: 190.83±22.61, 316.65±37.88, both P < 0.05). Furthermore, all the above parameters in the MSC-shLATS2 group were significantly improved as compared with those in the MSC-shcontrol group (all P < 0.05). LWW/BW ratio in the MSC-shLATS2 group was significantly lower than that in the ARDS group and the MSC-shcontrol group (mg/g: 9.85±1.51 vs. 16.78±1.92, 14.88±1.74, both P < 0.05).

CONCLUSIONS: Inhibiting Hippo signaling pathway by low expression of LATS2 could promote the retention of mMSCs in lung tissue and differentiation into AEC II cells of ARDS mice, improve pulmonary edema and alveolar epithelial permeability, regulate pulmonary inflammatory response, and alleviate pathological damage and fibrosis of lung tissue.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Li L, Dong L, Gao F, et al. [Effects of Hippo signaling pathway on lung injury repair by mesenchymal stem cells in acute respiratory distress syndrome]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019. PMID: 30914086. doi:10.3760/cma.j.issn.2095-4352.2019.03.005

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。